Brief: BridgeBio Pharma Q1 Net Income USD -169.608 Million Vs. IBES Estimate USD -179.7 Million
29/04/2025 21:01
Apr 29 (Reuters) - BridgeBio Pharma Q1 basic EPS USD -0.88. Q1 revenue USD 116.6 million vs. IBES estimate USD 61.9 million Q1 operating income USD -104.372 million vs. IBES estimate USD -157 million
Recent news on BridgeBio Pharma
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
BridgeBio rises on FDA priority review for dwarfism drug
Brief: Bridgebio Announces FDA Acceptance And Priority Review Of NDA For Oral Infigratinib For Children With Achondroplasia
Brief: Bbp-418 Demonstrates Potential To Be Disease Modifying Therapy, Restoring Cardiac And Disease Markers To Unaffected Levels